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Background: The application of statistics in reported research in trauma and orthopaedic surgery has become ever
more important and complex. Despite the extensive use of statistical analysis, it is still a subject which is often not
conceptually well understood, resulting in clear methodological flaws and inadequate reporting in many papers.
Methods: A detailed statistical survey sampled 100 representative orthopaedic papers using a validated
questionnaire that assessed the quality of the trial design and statistical analysis methods.
Results: The survey found evidence of failings in study design, statistical methodology and presentation of the
results. Overall, in 17% (95% confidence interval; 10–26%) of the studies investigated the conclusions were not
clearly justified by the results, in 39% (30–49%) of studies a different analysis should have been undertaken and in
17% (10–26%) a different analysis could have made a difference to the overall conclusions.
Conclusion: It is only by an improved dialogue between statistician, clinician, reviewer and journal editor that the
failings in design methodology and analysis highlighted by this survey can be addressed.Background
Statistics is an essential component of medical research
from design initiation to project reporting, and it influ-
ences all aspects of the research process from data collec-
tion and management to analysis and interpretation. The
application of statistics to medical sciences, and particu-
larly in our area of interest, trauma and orthopaedic sur-
gery, has become more widespread and complex.
However, there is considerable evidence, both anecdotal
and in the literature [1], of poor reporting and use of stat-
istical methods in orthopaedics papers. Although our ex-
perience providing statistical support more widely in
medicine leads us to suspect that similar opinions, about
the quality of both design and statistical analysis, exists
within many other medical disciplines. So our selection of
general orthopaedic journals is not solely to highlight par-
ticularly bad practice in this discipline, as we suspect much* Correspondence: nick.parsons@warwick.ac.uk
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reproduction in any medium, provided the orof what we report here is generally applicable to research
across all disciplines, and as such orthopaedic publications
simply provide an exemplar of this larger population. In an
attempt to quantify the extent of poor reporting and use of
statistical methods, Parsons et al. [2] undertook a large
survey of the orthopaedic literature to assess both the
quality of reporting and the appropriate and correct use of
statistical methods. The first part of this study found major
deficiencies in reporting, with 59% (95% confidence inter-
val; 56–62%) and 58% (56–60%) compliance with CON-
SORT [3] and STROBE [4] guidelines, and commented on
differences between journals and paper types [2]. In the
second part of the study, the quality of statistical analysis
methods was assessed using a detailed questionnaire which
was completed for a random sample of orthopaedics
papers by two experienced statisticians. The results of this
survey are discussed in detail here.
Methods
A random sample of 100 papers from the general ortho-
paedic literature was obtained and included 27l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(CC) studies, 16 longitudinal (L) studies and 27 cross-
sectional (CS) studies. The sample was stratified by study
type to ensure accurate representation of each of the four
types of study and additional inclusion criteria were as
follows:
(i) Published research papers from seven general
orthopaedic journals [5] covering a range of impact
factors [6]; Journal of Bone and Joint Surgery
(American), Clinical Orthopaedics and Related
Research, Journal of Bone and Joint Surgery (British),
Acta Orthopaedica, Archives of Orthopaedic and
Trauma Surgery, International Orthopaedics and
BMC Musculoskeletal Disorders
(ii) Original research only – excluding trial protocols,
reviews, meta-analyses, short reports,
communications and letters
(iii)Published between 1st January 2005 and 1st March
2010 (study start date)
(iv)No more than one paper from any single research
group
(v) Papers published by research groups based at our
own institutes were excluded to avoid assessment bias
Full details of the search strategy and methods used to
collect the sample are provided by Parsons et al. [2].
The statistical quality of each paper was assessed using a
validated questionnaire [7], which was adapted to reflect
the specific application to orthopaedic research [2]. After
randomly numbering the papers from 1 to 100, each paper
was read and independently assessed using the question-
naire by two experiences statisticians (NP and CP). Even
numbered papers were read by NP and odd numbered
papers were read by CP. The questionnaire was divided
into two parts. Part one captured data describing the type
of study, population under study, design, outcome mea-
sures and the methods of statistical analysis and the
results of this were reported in Parsons et al. [2]. A ran-
dom sample of 16 papers from the original 100, stratified
by study type to ensure balance, was selected and read by
both statisticians to assess the level of agreement between
the two reviewers for individual items on part one of the
questionnaire. Parsons et al. [2] reported kappa statistics
in the range 0.76 to 1.00 with a mean of 0.96 suggesting
good agreement between the reviewers for this more ob-
jective part of the survey. The second part of the question-
naire required generally more subjective assessments
concerning the presentation of data and the quality and
appropriateness of the statistical methods used (see Add-
itional file 1 for questionnaire details). The results of this
part are reported in detail here. The survey allowed a
detailed investigation of issues such as the description of
the sample size calculation, missing data, the use ofblinding in trials, the experimental unit, multiple testing
and presentation of results.
The correctness, robustness, efficiency and relevance [7]
of the statistical methods reported in the sample papers
were assessed using a yes or no assignment for each char-
acteristic. Correctness refers to whether the statistical
method was appropriate. For instance, it is not correct to
use an unpaired t-test to compare an outcome from base-
line to the trial endpoint for a single group of patients.
Many statistical methods rely on a number of assumptions
(e.g. normality, independence etc.); if those assumptions
are incorrect, the selected method can produce misleading
results. In this context we would describe the selected
methods as lacking robustness. A statistical method was
rated as inefficient if, for example, a nonparametric rather
than a parametric method was used for an analysis where
data conformed to a known distribution (e.g. using a
Mann–Whitney test, rather than a t-test). Finally, an ana-
lysis was regarded as relevant if it answered the question
posed in the study. For instance, a principal components
analysis may be correct and efficient for summarising a
multivariate dataset, but may have no bearing on the sta-
ted aim of a paper.
The majority of the survey items were objective assess-
ments of quality, e.g. an incorrect method of analysis
was used, with a small number of more subjective items,
e.g. could a different analysis make a difference to the
conclusions?
Results
The outcomes of part two of the statistical questionnaire
are summarized in the following three subsections cov-
ering study design, statistical methods and the presenta-
tion of results.
Study design
A number of key themes emerged from the analysis of
the questionnaire data. Foremost amongst these were
the description of the study design, identification of the
experimental unit, details of the sample size calculation,
the handling of missing data and blinding for subjective
measures. These topics are discussed individually below.
(i) Experimental unit
The experimental unit is a physical object which can
be assigned to a treatment or intervention. In
orthopaedics research, it is often an individual
patient. However, other possibilities include things
such as a surgeon, a hip or a knee. The experimental
unit is the unit of statistical analysis and, for simple
study designs, it is synonymous with the data values,
i.e. there is a single outcome measure for each
experimental unit. For more complex designs, such
as repeated measures, there may be many data
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correctly identify the experimental unit is a common
error in medical research, and often leads to
incorrect inferences from a study [1,8].
The experimental unit was not identified correctly in
23% (15–33%; 95% confidence interval based on
normal approximation to binomial) of the sampled
studies. Of the 77 papers that correctly identified the
experimental unit, 86% (75–92%) correctly
summarised the data by patient. By far the most
common reason for incorrect identification of the
experimental unit was confusion between limbs and
individual patients when analysing and reporting
results. For example, one paper reported data for
100 patients but summarised outcomes for 120 feet,
whereas another reported patient pain scores after
surgery for both left and right ankles on some
patients and single ankles for other patients. Failure
to identify the correct experimental unit can lead to
‘dependencies’ in data. For example, outcome
measures made on left and right hips for the same
patient will be correlated, but outcome measures
between individual hips from two different patients
will be uncorrelated. Only one paper, where data
were available from one or both legs for patients,
identified this as an important issue and the authors
decided to use what we would regard as an
inappropriate strategy by taking the mean of the two
values as the outcome for bilateral patients. Almost
all of the statistical analyses reported in these studies
(e.g. t-tests, ANOVA, regression) are based on an
assumption that outcome data (formally the
residuals) are uncorrelated; if this is not the case
then the reported inferences are unlikely to be valid.(ii) Sample size
The size of the sample used in a study, i.e. the
number of experimental units (usually patients),
largely determines the precision of estimates of study
population characteristics such as means and
variances. That is, the number of patients in the study
determines how confidently we can draw inferences
from the results of that study and use them to inform
decisions about the broader population of patients
with that particular condition or problem. In clinical
trials, a pre-study power analysis is usually used to
estimate the sample size [9], although methods are
available for many other study types [10]. It is
particularly important for RCTs, where specific null
hypotheses are tested, that a clear description of the
methodology and rationale for choosing a sample size
is given. For example, the outcome is assumed to benormally distributed, treatment group differences will
be assessed using a t-test, the power to detect a
defined clinically meaningful difference is set to at
least 80% and the type I error rate, or significance
level, is set to 5%.
The sample size was not justified in the Methods
section for 19% (7–39%) of the 27 papers describing
RCTs. A specific calculation, with sufficient details
to allow the reader to judge the validity, was not
given for 30% (14–50%) of RCTs. These studies
often simply described the sample size in vague
terms, for instance ". . .based on a priori sample size
estimation, a total of 26 patients were recruited. . .".
For 3 papers reporting RCTs, the validity of the
sample size calculation was questionable, for 3
papers there was a lack of clearly stated
assumptions and in 2 papers the calculation was
simply not credible. For example, one paper gave
sparse details about the population variance,
minimum clinically important difference and
required power which resulted in a recruitment
target of 27 patients for a two arm trial. For purely
practical reasons one would always want an even
number of patients in a two arm trial. In another
paper, 400 patients were recruited to a study, based
on a vague description about how this number was
arrived at, and exactly 200 patients were randomly
allocated to each of two treatment groups. A cynical
reader might question the likelihood of such an
exact split of patients between treatment groups;
there is only a 1 in 25 chance of an exact split for a
simple 1 to 1 randomization. However, this might
simply be a case of poor reporting, where in reality
blocking or minimization were used to equalise
numbers in the treatment arms, thus giving more
credence to the description of the design. For the 73
observational studies, only 34% (24–46%) justified
the sample size, that is there was some discussion in
the paper on how the sample size was arrived at;
this was often minimal, for instance a simple
statement that the number of patients required to
answer the research question was the number of
patients who were available at the time of study, or
those who accepted an invitation to participate (e.g.
". . .all patients were invited to join the study. . .").(iii) Missing data
Missing data are observations that were intended to
be made but were not made [11]; the data may be
missing for unexpected reasons (e.g. patient
withdrawal from a study), or intentionally omitted or
not collected. It is important to carefully document
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reporting. If data can be considered to be missing at
random, then valid inferences can still be made.
However, if values are missing systematically, then it
is more dangerous to draw conclusions from that
study. For example, if in a clinical trial comparing
different types of hip replacement all of the missing
data occurs in one particular arm of the trial, the
remaining data is unlikely to be representative of the
overall result in that group of patients; the missing
data may be because those patients went to another
hospital for their revision surgery.
Data were missing, either for a complete unit or a
single observation, in 34% (25–44%) of the papers,
of these 34 papers only 62% (44–77%) documented
and explained the reasons for this. An audit of the
data reported in each paper allowed the statistical
assessors to identify 13 papers (13% of the total
sample) where data were missing with no
explanation. Data missingness was generally
inferred from the numbers reported in the results
being less than those reported in the methods, with
no explanation or reason offered by the authors of
the study. In the 34 papers reporting missing data,
28 based the analysis on complete cases, 2 imputed
missing data and for the remaining 4 papers it was
unclear as to what methodology was used.(iv) Subjective assessments and blinding
Many orthopaedic studies report subjective
assessments, such as a pain or a functional score
after surgery or a radiological assessment of the
quality of a scan. To reduce the risk of bias for
these kinds of assessments it is desirable, where
possible, to ‘blind’ the assessor to the treatment
groups to which the patient was allocated.
Subjective assessments were undertaken in 16 of the
27 RCTs (59%; 95% CI 39–77%) and in 6 of these
studies (38%; 95% CI 16–64%), the assessments were
not done blind and no explanation was given as to
why this was not possible.Statistical methods
Statistical methods should always be fully described in
the methods section of a paper and only the statistics
described in the methods should be reported in the
results section. In 20% (13–29%) of the papers in our
survey, statistical methods not previously stated in the
methods section were reported in the results section [2].
In addition to the poor reporting of the methods used, a
number of specific issues were identified.(i) Analysis methods
The most commonly reported statistical methods
were chi-squared (χ2) and Fisher’s exact tests (47%;
95% CI 37–57%), t-tests (45%; 95% CI 35–55%),
regression analysis (33%; 95% CI 24–43%) and Mann–
Whitney tests (28%; 95% CI 20–38%). The selection of
an appropriate method of analysis is crucial to making
correct inferences from study data.
In 52% (32–71%) of papers where a Mann–Whitney,
Wilcoxon rank sum or Wilcoxon signed rank test
was used, the analysis was considered to be
inefficient and the reported analysis was only
considered to be correct 70% (50–86%) of the time.
The t-test was used inappropriately, with a lack of
robustness, in 26% (14–41%) of papers and in an
equivalent proportion of papers (26%; 95% CI 14–
41%) it was reported in such a way as to be
irrelevant to the stated aims of the paper. This lack
of relevance was, on occasion, due to method
selection such as the choice between a parametric
and a nonparametric test, but more often was simply
a result of poor reporting and lack of clarity in the
description. Many papers reported a list of the
statistical tools used in the analysis, but in the results
gave only short statements such as “A was better than
B (p= 0.03)” with no details as to which test was used
to obtain the p-value; so-called ‘orphan’ p-values [12].
It was therefore impossible to assess whether the
correct test was used for the relevant comparison.
Seven papers (7%; 95% CI 3–14%) reported clear
methodological errors in the analysis. Two papers
wrongly used the Wilcoxon signed-rank test to
compare independent samples and another paper used
an independent samples t-test where a paired test
should have been used. One paper committed the
reverse error of using a paired t-test to compare cases
and controls in an unpaired case–control study and
another paper used a t-test to compare differences in
proportions rather than, for instance, a χ2 test.
Another study calculated the arithmetic mean of a
number of percentages, all based on different
denominator populations. And finally, one study
outlined reasons for conducting a non-parametric
analysis in the methods only to later report an analysis
of covariance, a parametric method of analysis based
on assumptions of normality.
(ii) Parametric versus non-parametric tests
Parametric statistical tests assume that data come
from a probability distribution with a known form.
That is, the data from the study can be described by
a known mathematical model; the most widely used
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inferences about the parameters of the distribution
based on estimates obtained from the data. For
example, the arithmetic mean and variance are
parameters of the normal distribution measuring
location and spread respectively. Non-parametric
tests are often used in place of parametric tests
when the assumptions necessary for the parametric
method do not hold; for instance the data might be
more variable or more skewed than expected.
However, if the assumptions are (approximately)
correct, parametric methods should be used in
preference to non-parametric methods as they
provide more accurate and precise estimates, and
greater statistical power [13].
Many of the papers in this survey showed no clear
understanding of the distinction between these
types of tests, evidenced by reporting that made no
statistical sense: e.g. ". . .continuous variables were
determined to be parametric using Kolmogorov-
Smirnov tests. . .", ". . .the t-test was used for
parametric variances. . .", ". . .non-parametric
statistics were used to compare outcome measures
between groups (one way ANOVA). . ." and
". . .Student's t-test and the Mann–Whitney test were
used to analyse continuous data with and without
normal distribution. . .". Continuous variables may
be assumed to be approximately normal in an
analysis, but it makes no sense to describe variables
or variances as parametric. It is also incorrect to
label an analysis of variance (ANOVA) as non-
parametric. In at least 5 papers (5%; 95% CI 2–12%),
the authors opted to use non-parametric statistical
methods, but then summarised data in tables and
figures using means and standard deviations, the
parameters of the normal distribution, rather than
correctly using medians and ranges or inter-quartile
ranges.
The survey showed that 52% (42–62%) of papers
used non-parametric tests inefficiently; that is they
reported the results of non-parametric tests for
outcomes that evidence from the paper suggested
were approximately normal. Three papers (3%; 95%
CI 0–9%) compared the lengths of time to an
outcome event between groups by using the non-
parametric Mann–Whitney (M-W) test based on
converting the times to ranks. By doing this, much
of the information about real differences between
individual records is lost; for example outcomes of
1 day, 2 days and 100 days become 1, 2 and 3 when
converted to ranks. Although times are often
positively skewed, they are usually approximately
normally distributed after logarithmic
transformation [14]. A more efficient analysis cantherefore usually be achieved by using a t-test on
log-transformed times rather than applying a M-W
test to untransformed data. This is not to say that
non-parametric tests should never be used, but that
for many variable types (e.g. times, areas, volumes,
ratios or percentages) there are simple and well-
known transformations that can be used to force
the data to conform more closely to the
assumptions required for parametric analysis, such
as normality or equality of variances between
treatment groups.(iii) Multiple comparisons
Problems of multiple comparisons, or multiple
testing, occur when considering the outcomes of
more than one statistical inference simultaneously.
In the context of this survey, it is best illustrated by
considering a number of reported statistical tests
for one study all reporting evidence for significance
at the 5% level. By definition, if one undertakes 20
hypothesis tests on data where we know that there is
no true difference, we will expect to see one
significant result at the 5% level by chance alone.
Therefore, if we undertake multiple tests, we require
a stronger level of evidence to compensate for this.
For example, the Bonferroni correction preserves the
‘familywise error rate’ (α), or the probability of
making one or more false discoveries, by requiring
that each of n tests should be conducted at the α/n
level of significance, i.e. it adjusts the significance
level to account for multiple comparisons [15].
The questionnaire recorded the number of
hypotheses tested in each paper, based on an
approximate count of the number of p-values
reported. Three papers did not report p-values, 31
papers (31%; 95% CI 22–41%) reported less than 5
p-values, 36 papers (36%; 95% CI 27–46%) reported
between 5 and 20 p-values and 30 papers (30%;
95% CI 21–40%) reported more than 20 p-values.
Issues of the relevance and the need for formal
adjustment for multiple comparisons will clearly be
very problem specific [16]. Whilst most statisticians
would concede that the formal adjustment of p-
values to account for multiple comparisons may
not necessarily be required when reporting a small
number of hypothesis tests, if reporting more than
20 p-values from separate analyses, some discussion
of the rationale and need for so many statistical
tests should be provided and formal adjustment for
multiple-comparison considered. In an extreme
case, one paper reported a total of 156 p-values
without considering the effect of this on inferences
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significance level would have resulted in at least 21
of the 35 reported significant p-values in this study
to be regarded as no longer significant. Where
some adjustment was made for multiple
comparisons (7 papers), the Bonferroni correction
was the most common method (5 papers). One
other paper used Tukey’s Honestly Significant
Difference (HSD) test and another set the
significance level to 1% (rather than 5%) in an ad-
hoc manner to account for undertaking 10 tests.Presentation of results
The clear and concise presentation of results, be it the
labelling of tables and graphs or the terminology used to
describe a method of analysis or a p-value, is an import-
ant component of all research papers. The statistical as-
sessment of the study papers identified two important
presentational issues.
(i) Graphs and tables
The statistical assessors were asked to comment on
the quality of the data presentation in the papers
which included tables and graphs. Graphs and tables
were clearly titled in only 29% (21–39%) of papers.
For instance, typical examples of uninformative
labels included “Table I: Details of Study” and “Table
II: Surgical Information”. Furthermore, only 43% of
graphs and tables were considered to be clearly
labelled. In particular, a number of the papers
included tables with data in parentheses without
further explanation. The reader was then left to
decide whether the numbers indicated, for example,
95% confidence intervals, inter-quartile ranges
(IQRs) or ranges. Some tables also included p-values
with no indication of the statistical test used. The
description of graphical displays was occasionally
confusing. One paper stated that the bars of a box-
and-whisker plot represented the maximum and
minimum values in a dataset, when there were
clearly points outside the bars. By convention, the
bars represent 1.5 times the inter-quartile range,
with points outside the bars identified as ‘outliers’.
Interestingly, another paper claimed that the boxes
showed standard deviations, rather than the correct
IQR, so there is clearly a wider misunderstanding of
these figures.
Raw data for individual patients (or experimental
units) were displayed graphically or in tables in only
9% (4–17%) of papers. Raw data, as opposed to
means, medians or other statistics, always provide
the simplest and clearest summary of a study, and
direct access to the data for the interested reader.
Although we accept that there may be practicalreasons why authors would not want to present such
data, it is disappointing that such a small proportion
of investigators decided to do so.(ii) Terminology
The lack of appropriate statistical review, either
prior to submission or at the review stage, was
apparent in the catalogue of simple statistical
reporting errors found in these papers. For instance,
methods were reported that, to our knowledge, do
not exist: e.g. "multiple variance analysis" or the
“least squares difference" post-hoc test after
ANOVA. Presumably the latter refers to a least
significant difference test, but the former is
ambiguous. Another class of reporting error were
those that simply made no statistical sense in the
context they were reported: e.g. ". . .there was no
difference in the incidence among the corresponding
groups (chi-squared test, p = 0.05). . .", and ". . .there
were no significant differences in the mean T-score or
Z-score between the patients and controls. . .". The
former remark was made in the context of rejecting
the null hypothesis at the 5% level for significance
and the latter presumably implied that mean t-
statistics and z-scores were compared between
groups, which makes no statistical sense. The
inadequate or poor reporting of p-values was also
widespread, and typical errors included
"p < 0.000009", “p < 0.134” and, more generally, the
use of “p=NS” or “p< 0.05”. P-values should generally
be quoted to no more than 3 decimal places, and be
exact (as opposed to an inequality e.g. p < 0.05),
unless very small when p< 0.001 is acceptable.Discussion
A number of key issues have emerged from our survey
of 100 papers investigating the quality of statistical ana-
lysis and design in trauma and orthopaedic research.
These points are summarised below with recommenda-
tions for improvement.
Experimental unit
It is important that authors clearly identify the experi-
mental unit when reporting. This was a source of confu-
sion for 23% (95% CI 15–33%) of the papers in our
survey and reflects a fundamental lack of understanding.
If no attempt is made to modify the analysis to account
for data dependencies, researchers should at least state
that they are making an assumption of (approximate) in-
dependence between multiple observations for the same
unit (e.g. functional outcomes from the left and right
side for the same individual after a bilateral procedure).
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the assumption is reasonable in the context of the study.
Sample size
Where specific hypotheses are being tested, for instance in
an RCT, the sample size should be discussed, and usually a
power calculation reported with sufficient details to allow
one to verify the reported sample size. In this survey, 30%
(14–50%) of the RCTs gave no such calculation and 19%
(7–39%) of them provided no justification for the sample
size in the methods section. A clear description of the meth-
odology used for sample size determination (e.g. power level,
significance) and the design used (e.g. randomization) is crit-
ical for judging the quality of research. However, in studies
where a sample size calculation may not be relevant, for ex-
ample if the research is exploratory or researchers have ac-
cess to a limited number of participants, authors should
provide an open discussion of this in the methods section.
Missing data
The lack of a clear explanation offered by a number of
the papers in this survey for missing data goes hand-in-
hand with the poor reporting of patient numbers. Par-
sons et al. [2] showed that only 57% of these papers sta-
ted exact numbers of patients in both the methods and
results sections. RCTs should report a (CONSORT-style
[3]) flowchart documenting exactly what happened to all
of the participants in the trial, and all studies should state
how and why any patient data was missing or excluded
from the analysis. Furthermore, all studies should state the
size of sample used to estimate parameters, as a way of ex-
plicitly stating whether all or only partial information was
available for inference.
Blinding
It is important for the credibility of reported research to
take all practical steps to remove potential sources of
bias from a study. Blinding an assessor to the treatment
allocation in RCTs is a simple method to achieve this.
We expect that when subjective scores are used then
blinding is necessary, or if blinding is not possible some
explanation should be offered as to why it was not pos-
sible or practical.
Analysis methods
This survey has highlighted the common use of inefficient
or irrelevant statistical methods, with 7 papers reporting
clear methodological errors. Not only does this suggest
that many of the studies reported in these papers have had
little or no expert statistical input, it is clear that many of
the papers have not undergone adequate statistical review
prior to publication. The lack of clear association between
the description of the statistical methods and the reporting
of the outcome (e.g. p-value) was widespread. However,this kind of issue could be easily corrected by obtaining
appropriate expert statistical review prior to submission. If
a reviewer notes a statistical error, or does not understand
a statistical analysis plan, they should recommend that an
expert opinion is sought during the review process after
submission to the journal.Parametric versus non-parametric tests
Non-parametric tests were used widely in the studies in this
survey in a manner that suggested a lack of understanding
as to when they are appropriate. For instance when select-
ing between a (parametric) t-test or a (non-parametric)
Mann–Whitney test, the latter test should only be used for
outcomes that are not approximately normally distributed
and should be reported with medians and ranges (or inter-
quartile ranges), not means and standard deviations [13].
However, where a natural transformation is available to
make an outcome ‘more normal’, undertaking the analysis
on the transformed scale using normal test statistics is
usually a more efficient and powerful option than the
non-parametric alternative. The widespread misuse of
non-parametric tests in this survey suggests that this issue
is not widely appreciated.Multiple comparisons
Carrying out multiple hypothesis tests was a common prac-
tice in many of the papers reviewed, with 30% (21–40%) of
the papers reporting over 20 p-values and one study report-
ing a massive 156. Whilst we accept that the details of statis-
tical methods to correct for multiple comparisons may not
be common knowledge in the orthopaedic research com-
munity, and the circumstances when it is appropriate to ad-
just for multiple testing remain contentious amongst both
statistical and clinical communities [16], we would expect
most researchers to have some appreciation that carrying
out large numbers of hypothesis tests and reporting signifi-
cance at the standard 5% level is bad practice. We would ad-
vise that often the best way of dealing with this issue is to
insist that a clear description and justification of all tests of
significance that have been performed be included; this
process of questioning will generally lead to a marked reduc-
tion in the number of tests reported. Graphs and tables:
The presentation of results was a particular weak point in
the papers included in this survey. All graphs and tables
should be clearly labelled and sufficiently detailed to allow at
least some inference to be made in isolation from the rest of
the paper. Authors should include a clear title so that read-
ers can quickly understand the information on display with-
out reference to the main body of the text. With the
increasing availability of software for producing sophisti-
cated plots, it is tempting for authors to indulge in novel
ways to present results. However, this is often one area
where clear and simple tends to be best.
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tionnaire, we noted that 5 of the 27 RCTs (19%; 95% CI
7–39%) tested for differences between baseline charac-
teristics (e.g. age, gender ratio, BMI etc.) after recruit-
ment and randomization of patients to treatment arms
of a trial. Since the randomization process produces
treatment groups that are random samples from the
same population, a null hypothesis of no difference be-
tween two populations must, by definition, be true. As
such, any significant difference observed between groups
must have arisen by chance; i.e. it is a type I error. Des-
pite the widespread appreciation of this argument within
the statistics community, this is still a widely reported
error in many medical disciplines that, with adequate
statistical input during the course of a study and at re-
view, could be avoided.
Conclusion
The opinions expressed here are the result of independ-
ent assessments made by two statisticians using a sample
of 100 representative orthopaedic papers and, as such,
are limited by the experience and prejudices of the
assessors and the size and nature of the survey. How-
ever, the carefully designed sampling strategy and the
random selection methods ensured that the papers sur-
veyed were indeed representative of the target literature
[2]. Furthermore, the fact that many of the issues high-
lighted in this paper are familiar topics to those provid-
ing statistical reviews of medical research [17], suggests
that the views expressed here are likely to be widely held
within this community. For those who are unfamiliar
with good practice in research, others have provided
guidance in the use of statistics in the orthopaedic set-
ting [1,18] and also specifically in the design of RCTs
[19,20]. More generally, the series of short articles on
the use of statistics for medical researchers published
in the British Medical Journal [21] provide a rich re-
source of information on good statistical practice. Al-
though our focus here has been on research published
in general orthopaedic journals, the nature and extent
of the issues raised here are clearly not exclusive to this
discipline and as such we expect that the issues raised
in the discussion and our recommendations for im-
provement to be applicable across all medical disci-
plines. To the non-statistically trained reader, many of
the criticisms reported here may seem niggling and un-
important relative to the clinical details of a study.
However, it is troubling to report that the statistical
assessors in this survey thought that in 17% (10–26%)
of the studies, the conclusions were not clearly justified
by the results. For 39% (30–49%) of studies a different
analysis should have been undertaken and for 17% (10–
26%) of them, a different analysis could have made a
difference to the conclusions. The results of this surveypresent challenges for us all, whether statistician, clinician,
reviewer or journal editor, and it is only by greater dia-
logue between us all that these important issues can be
addressed.
Additional file 1
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